• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Shimadzu forms pact with Acuson

Article

The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.

The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.

Shimadzu officials will use the 128 XP/4 Advanced to fill aneed for a mid-tier color-flow system in its domestic productline, according to Yuji Shimizu, project leader of medical systemsmarketing at Shimadzu.

"We see this as an opportunity to expand our market share,"he said.

The alliance will enable Acuson to take advantage of Shimadzu'straditionally strong relationships with physicians in Japan'scommunity and public hospitals, said Judy Barton, Acuson's marketingmanager for Asia/Pacific and Latin American regions.

The manufacturer's Japanese subsidiary Acuson Nippon will continueto provide installation, training and service support for theXP/4 installed base, Barton said. It also spearheads Acuson'ssales of the high-performance 128 XP/10 to large hospitals anduniversity-based facilities in Japan, she said. No financial termswere disclosed.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.